Young investigator group at HZB: Scaling perovskite cells

Dr. Eva Unger leads the Young Investigator Group Hy-Per-FORME.

Dr. Eva Unger leads the Young Investigator Group Hy-Per-FORME. © privat

The new Young Investigator Group Hy-Per-FORME led by Dr. Eva Unger is working on scaling all processing steps to enable manufacturing of perovskite solar cells on larger areas, thus brigding he gap between lab and industry.

Dr. Eva Unger is starting a Young Investigator Group (YIG) at HZB, co-financed by the Federal Ministry for Education and Science (BMBF). The activities of the Unger group will be an important contribution within the newly-founded HySPRINT Innovation lab aiming at the realization of large-area, stable and efficient hybrid tandem device technology based on a combination of established silicon photovoltaic technology and emerging perovskite semiconductor devices.

To achieve this goal, developing and optimizing scalable deposition methods for the recently evolved hybrid perovskite semiconductors is one of the key aspects. The YIG of Unger therefore focusses on the formation and scaling the deposition of hybrid perovskite semiconductors using slot-die coating and ink-jet printing as a solution-based processing technology.

Originally from Germany, Eva Unger did her PhD at Uppsala University, Sweden and carried out postdoctoral work at Stanford University and Lund University through a stipend from the swedish Marcus and Amalia Wallenberg Foundation. Prior to starting the YIG, she has been working as a visiting researcher at Helmholtz Center Berlin funded by an International Career Grant co-funded by the Swedish Research Council and Marie-Skłodowska-Curie Actions. She will be co-affiliated with Lund University, Sweden and aims to strengthen cooperations with Lund University, Vrije Universiteit Amsterdam and the Universities in Berlin and Brandenburg.

red.

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.